program, you must have a master's degree or equivalent in biological sciences, natural sciences, human or veterinary medicine, or a biomedical engineering discipline. In addition, you must have research
for Pediatric Pneumology, Allergology and Neonatology at Hannover Medical School. After studying human medicine at the Ruhr-Universität-Bochum and the Charing Cross and Westminster Medical School London
cell-enhanced bioimplants. Our PhD students hold a Master's degree or equivalent in life sciences, human or veterinary medicine, or in an engineering discipline. In October 2007 the PhD program ‘Regenerative
MHH intranet from outside and use programs) HISQIS (printing of study certificates) FACTScience (human medicine and dentistry: curricula) MS Teams (tool for collaboration, communication and video conferencing)
Curth, S. Moniot, S. Mosalaganti, S. Raunser and C. Steegborn (2013). Molecular architecture of the human protein deacetylase Sirt1 and its regulation by AROS and resveratrol. Biosci Rep 33(3) . Naue, N. [...] Letters 430, 197-200 Yang, C., Curth, U., Urbanke, C. and Kang, C.-H. (1997) Crystal structure of human mitochondrial single-stranded DNA binding protein at 2.4Å resolution Nature structural biology 4, [...] single-stranded DNA: Structural comparison of the single-stranded DNA-binding proteins from E. coli and human mitochondria FEBS Letters 411, 313-316 . Curth, U., Genschel, J., Urbanke, C. and Greipel, J. (1996)
Health (IDOH) Human - Animal - Environment Here you will learn the basics of various infectious diseases with special reference to zoonotic agents, pathogens that can jump from animals to humans. ⇒ to the
cellular actin dynamics and drives functional compartmentalization of the actin cytoskeleton. Several human diseases are directly associated with impaired cytoskeletal actin dynamics. Non-muscle actinopathies
team investigated whether the Meg3 inhibitor could also stop fibrosis and improve heart failure in human heart muscle cells and heart tissue. "Our revolutionary technology worked excellently," the cardiologist
ACT-COVID19-Study A Phase I/ Randomized Phase II Trial To Analyse Safety And Efficacy Of Human SARS-COV-2-Specific T Lymphocyte Transfer In Patients With COVID-19 In Need Of Treatment Or At Risk Of Severe
l cohorts could enable more accurate cancer risk prediction," says Penkert from the Institute of Human Genetics, who is currently conducting research in Professor Kratz's team. A total of 141 people from